Selumetinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Selumetinib
Health Canada Patents

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Selumetinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 1 USDMF, 2 NDC API, 2 Listed Suppliers, $ API Reference Price

3 API Suppliers
1 USDMF
2 NDC API
2 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

54 Drugs in Development

54 Drugs in Development

FINISHED DOSAGE FORMULATIONS

8 FDF Dossiers, 2 FDA Orange Book, 2 Europe, 2 Australia, 2 South Africa

8 FDF Dossiers
2 FDA Orange Book
2 Europe
2 Australia
2 South Africa

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 21 News #PharmaBuzz

1 Data Compilation #PharmaFlow
21 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Regulatory FDF Prices, 5 Annual Reports

1 US Medicaid Prescriptions
2 Regulatory FDF Prices
5 Annual Reports

MARKET PLACE

3 APIs, 1 FDF Dossiers

3 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

14 US Patents, 4 US Exclusivities, 6 Health Canada Patents

14 US Patents
4 US Exclusivities
6 Health Canada Patents

$ API Ref.Price (USD/KG) : 94,852 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 4Alexion Pharma Canada Corp.

02 2AstraZeneca Canada Inc.

filter Patent Reset all filters

6 All

01 22478374

02 22634149

03 22718653

filter Product Reset all filters

6 All

01 6SELUMETINIB SULFATE

filter Dosage Reset all filters

6 All

01 6CAPSULE

filter Exp Date Reset all filters

6 All

01 22023-03-13

02 22026-12-12

03 22029-03-26

Product Main Page

01

AstraZeneca Canada Inc.

Selumetinib

Peptide Process CMC

Not Confirmed

AstraZeneca Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-03-13

Date Granted : 2009-01-06

Selumetinib

Brand Name : KOSELUGO

Patent Number : 2478374

Filing Date : 2003-03-13

Strength per Unit : 10 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-03-13

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Alexion Pharma Canada Corp.

Selumetinib

Peptide Process CMC

Not Confirmed

Alexion Pharma Canada Corp.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-12

Date Granted : 2013-08-13

Selumetinib

Brand Name : KOSELUGO

Patent Number : 2634149

Filing Date : 2006-12-12

Strength per Unit : 10 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-12-12

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Alexion Pharma Canada Corp.

Selumetinib

Peptide Process CMC

Not Confirmed

Alexion Pharma Canada Corp.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-26

Date Granted : 2016-02-09

Selumetinib

Brand Name : KOSELUGO

Patent Number : 2718653

Filing Date : 2009-03-26

Strength per Unit : 10 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-03-26

Date Granted : 2016-02-09

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

AstraZeneca Canada Inc.

Selumetinib

Peptide Process CMC

Not Confirmed

AstraZeneca Canada Inc.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-03-13

Date Granted : 2009-01-06

Selumetinib

Brand Name : KOSELUGO

Patent Number : 2478374

Filing Date : 2003-03-13

Strength per Unit : 25 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2023-03-13

Date Granted : 2009-01-06

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Alexion Pharma Canada Corp.

Selumetinib

Peptide Process CMC

Not Confirmed

Alexion Pharma Canada Corp.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-12

Date Granted : 2013-08-13

Selumetinib

Brand Name : KOSELUGO

Patent Number : 2634149

Filing Date : 2006-12-12

Strength per Unit : 25 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-12-12

Date Granted : 2013-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Alexion Pharma Canada Corp.

Selumetinib

Peptide Process CMC

Not Confirmed

Alexion Pharma Canada Corp.

Country

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-03-26

Date Granted : 2016-02-09

Selumetinib

Brand Name : KOSELUGO

Patent Number : 2718653

Filing Date : 2009-03-26

Strength per Unit : 25 mg

Dosage Form : CAPSULE

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-03-26

Date Granted : 2016-02-09

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!